GRUPO TMM S.A.B. ADS REPTG FIVE ORD PART CERT SER A SH
TMM
TMM was delisted on the 15th of June, 2012.
2 hedge funds and large institutions have $1.2M invested in GRUPO TMM S.A.B. ADS REPTG FIVE ORD PART CERT SER A SH in 2015 Q3 according to their latest regulatory filings, with funds opening new positions, 1 increasing their positions, 1 reducing their positions, and closing their positions.
105% more capital invested
Capital invested by funds: $584K → $1.2M (+$612K)
0% more funds holding
Funds holding: 2 → 2 (0)
0% more repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 1
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
FIM
Freedom Investment Management
Hartford,
Connecticut
|
+$26.9K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BMO
Beck Mack & Oliver
New York
|
-$7.5K |
TMM Hedge Fund Activity: Q3 2015 in Review
2 of the 3,590 institutional investors tracked by Wall St. Rank reported a position in GRUPO TMM S.A.B. ADS REPTG FIVE ORD PART CERT SER A SH (TMM) for Q3 2015, worth a combined $1.2M — up 105% from $584K a quarter earlier.
Fund positioning in TMM was balanced in Q3 2015: 0 funds opened new positions, 0 closed out, 1 added to existing stakes and 1 trimmed.
The largest buyer was Freedom Investment Management, adding an estimated $26.9K. The largest seller was Beck Mack & Oliver, cutting an estimated $7.5K.
- 2 institutional investors held GRUPO TMM S.A.B. ADS REPTG FIVE ORD PART CERT SER A SH (TMM) as of Q3 2015, unchanged from Q2 2015.
- Funds reported $1.2M of GRUPO TMM S.A.B. ADS REPTG FIVE ORD PART CERT SER A SH stock for Q3 2015, up 105% quarter-over-quarter.
- 0 funds opened new GRUPO TMM S.A.B. ADS REPTG FIVE ORD PART CERT SER A SH positions in Q3 2015 and 0 closed out.
- The largest GRUPO TMM S.A.B. ADS REPTG FIVE ORD PART CERT SER A SH buyer in Q3 2015 was Freedom Investment Management, an estimated $26.9K added.
- The largest GRUPO TMM S.A.B. ADS REPTG FIVE ORD PART CERT SER A SH seller in Q3 2015 was Beck Mack & Oliver, an estimated $7.5K sold.
Based on aggregated 13F filings for Q3 2015.